Free Trial

Neurocrine Biosciences (NBIX) Insider Trading & Ownership

Neurocrine Biosciences logo
$152.25 +2.66 (+1.78%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$147.30 -4.95 (-3.25%)
As of 05/8/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neurocrine Biosciences (NASDAQ:NBIX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.60%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$36.51M
Get NBIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neurocrine Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NBIX Insider Buying and Selling by Quarter

Neurocrine Biosciences Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/16/2026Sell36,400$132.70$4,830,280.00  
12/16/2025Sell1,190$155.09$184,557.10  
12/15/2025Sell5,000$152.23$761,150.00  
12/8/2025Sell4,376$159.65$698,628.40  
11/25/2025Sell15,000$143.37$2,150,550.00  
11/5/2025Sell18,000$151.82$2,732,760.00  
11/4/2025Sell300$141.97$42,591.00  
8/7/2025Sell106,322$126.41$13,440,164.02  
7/10/2025Sell457$135.00$61,695.00  
7/9/2025
Jude Onyia
Jude Onyia
Insider
Sell59,819$130.46$7,803,986.74  
7/2/2025
Jude Onyia
Jude Onyia
Insider
Sell20,362$130.13$2,649,707.06  
6/17/2025
Lisa C. McClain
Lisa C. McClain
House (R-MI)
Sell$124.88$1,001 - $15,000
6/11/2025
Lisa C. McClain
Lisa C. McClain
House (R-MI)
Buy$124.17$1,001 - $15,000
5/27/2025Sell9,613$120.38$1,157,212.94  
(Data available from 1/1/2013 forward)

NBIX Insider Trading Activity - Frequently Asked Questions

4.60% of Neurocrine Biosciences stock is owned by insiders. Learn more on NBIX's insider holdings.

The following insiders have sold NBIX shares in the last 24 months: Darin Lippoldt ($698,628.40), Gary A Lyons ($3,575,378.00), George J Morrow ($2,150,550.00), Ingrid Delaet ($1,452,037.27), Jude Onyia ($10,748,075.79), Julie Cooke ($4,002,866.70), Kevin Charles Gorman ($37,799,294.44), Kyle Gano ($14,421,965.87), Leslie V Norwalk ($945,707.10), Matt Abernethy ($4,719,018.09), Shalini Sharp ($156,941.40), Stephen A Sherwin ($5,338,400.00), and William H Rastetter ($8,129,092.50).

Insiders have sold a total of 683,843 Neurocrine Biosciences shares in the last 24 months for a total of $94,137,955.56 sold.

Lisa C. McClain (R-MI) has bought shares of Neurocrine Biosciences in the last year totaling $8,000. Lisa C. McClain (R-MI) has sold shares totaling $8,000.



This page (NASDAQ:NBIX) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners